The move is intended to help both trading liquidity and transparency for shareholders.
View full MXCT profile View Profile
April 08 2019
March 01 2019
February 06 2019
January 15 2019
November 14 2018
October 25 2018
The NYSE-listed company has designed a routine blood test to screen for colorectal and prostate cancers that reduces the need for more invasive colonoscopies and biopsies
March 07 2019
The Vancouver company is developing Omega-3 products as oil, powder or emulsion to be used as food additives
January 11 2019
The company sells clinically validated anti-ageing products for hair, skin and body.